Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu
Education
  • 1998 Dokuz Eylül University Faculty of Medicine Çocuk Hematolojisi ve Onkolojisi
  • 1995 Dokuz Eylül University, Onkoloji Institute, Professor Doktor
  • 1989 Dokuz Eylül University, Onkoloji Institute, Associate Professor Doktor
  • 1984 Dokuz Eylül University Faculty of Medicine Çocuk Sağlığı ve Hastalıkları
  • 1979 Ege University Faculty of Medicine
Experience
  • 2025 Acıbadem Healthcare Services
  • 2025 Dokuz Eylül University, Onkoloji Institute, Emeklilik
  • 1992 - 2025 Dokuz Eylül University, Onkoloji Institute, Faculty Member , Enstitü Müdürü
  • 2022 - 2024 Dokuz Eylül University, Faculty of Medicine , Dekan
  • 2012 - 2024 Dokuz Eylül University, Onkoloji Institute, Enstitü Müdürü
  • 1985 - 1992 Dokuz Eylül University, Faculty of Medicine , Çocuk Sağlığı ve Hastalıkları, Çocuk Onkolojisi Bilim Dalı, Faculty Member
Memberships
  • Türk Tabibler Birliği
  • International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN)
  • The Pediatric Oncology East and Mediterranean (POEM) Group
  • Türk Pediatrik Onkoloji Grubu (TPOG) Association
  • Türk Kanser Araştırma ve Savaş Vakfı
  • International Society of Paediatric Oncology (SIOP)
  • Türk Kanser Araştırma ve Savaş Kurumu Association, İzmir Şubesi
PUBLICATIONS
  • Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes J Clin Med. 2025 Jan 31;14(3):934 Olgun N, Arayici ME, Kızmazoglu D, Cecen RE.
  • Investigation of YAP-1, OTX-2, and nestin protein expressions in neuroblastoma: a preliminary study. Ann Clin Transl Neurol. 2024 Aug;11(8):2153-2165. Kum Özşengezer S, Altun ZS, Sanlav G, Baran B, Kızmazoğlu D, Aktaş S, Keskinoğlu P, Olgun N.
  • Low Expression of CASP8 Could be a Prognostic Biomarker in Neuroblastoma Patients. J Child Neurol. 2024 Oct;39(11-12):386-394. Altun Z, Ceyhan M, Yuan H, Kızmazoğlu D, Aktaş S, Olgun N.
  • Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma Gene. 2023 Apr 15;860:147233. Altun Z, Yuan H, Baran B, Aktaş S, Sönmez EE, Küçük C, Olgun N.
  • The association between birth weight and the risk of neuroblastoma: a meta-analysis of observational studies involving 4,361,141 participants. Am J Cancer Res. 2023 Sep 15;13(9):3854-3863. Olgun HN, Arayici ME, Cecen RE, Basbinar Y, Ellidokuz H.
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""